Most Popular
-
1
Yoon pushes for Xi’s visit to firm up ties with China
-
2
Esports legend Faker seeks to lead Korean surge at Asian Games
-
3
Incheon Airport passenger traffic to recover during Chuseok holiday
-
4
[Hello Hangeul] The making of Korean language textbooks featuring BTS
![[Hello Hangeul] The making of Korean language textbooks featuring BTS](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2023/09/24/20230924000121_0.jpg&u=)
-
5
Korea’s parental leave benefits lag behind OECD average
-
6
Seoul prepares for first major military parade in ten years
-
7
Korea trade volume sees sharp drop among OECD members
-
8
2m Koreans opt out of life-extending treatments
-
9
[Korea Beyond Korea] Early Koreanists 'on verge of extinction overseas'
![[Korea Beyond Korea] Early Koreanists 'on verge of extinction overseas'](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2023/09/25/20230925000556_0.jpg&u=20230925160918)
-
10
Chief justice seat at top court left vacant amid Assembly chaos
![[Hello Hangeul] The making of Korean language textbooks featuring BTS](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2023/09/24/20230924000121_0.jpg&u=)
![[Korea Beyond Korea] Early Koreanists 'on verge of extinction overseas'](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2023/09/25/20230925000556_0.jpg&u=20230925160918)
Shinhan Investment partners UK advisory firm to support bio firms’ overseas entry
By Choi Jae-heePublished : Nov. 15, 2021 - 14:00
Shinhan Investment said Monday it has signed a memorandum of understanding with PharmaVentures, a UK-based leading advisory firm providing whose main clients are health care life science companies, to diverse its investment banking services.
Under the partnership agreement, the two companies will boost cooperation in supporting South Korean biotech and pharmaceutical companies to advance to the global stage, while arranging international firms’ investments in the domestic health care market.
“We will provide differentiated IB services to help large and midsized bio firms to successfully make inroads into the global market,” said Jung Keun-soo, vice president and managing director of Shinhan Investment’s global investment banking division.
“In the coming year, (Shinhan Investment) will continue to carry out meaningful capital markets businesses to boost future growth industries.”
Founded in 1992, PharmaVentures handled more than 1,000 cases of mergers, acquisitions and joint venture activities for companies worldwide.
Under the partnership agreement, the two companies will boost cooperation in supporting South Korean biotech and pharmaceutical companies to advance to the global stage, while arranging international firms’ investments in the domestic health care market.
“We will provide differentiated IB services to help large and midsized bio firms to successfully make inroads into the global market,” said Jung Keun-soo, vice president and managing director of Shinhan Investment’s global investment banking division.
“In the coming year, (Shinhan Investment) will continue to carry out meaningful capital markets businesses to boost future growth industries.”
Founded in 1992, PharmaVentures handled more than 1,000 cases of mergers, acquisitions and joint venture activities for companies worldwide.
More from Headlines
![[Herald Interview] S&P economist tells Korea to brace for worst-case scenario with China](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2023/09/25/20230925000680_0.jpg&u=20230925173504)
![[Herald Interview] As a wanderer, Yoshitomo Nara does not confine himself to art](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2023/09/25/20230925000732_0.jpg&u=20230926110820)
